PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Reinier Postlaan 4, 6525 GC, Nijmegen, The Netherlands. roderick.maas@radboudumc.nl.\', \'Department of Health Evidence, Section Biostatistics, Radboud University Medical Center, Nijmegen, The Netherlands.\', \'Department of Neurology, University of Bonn, Bonn, Germany.\', \'German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.\', \'Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Reinier Postlaan 4, 6525 GC, Nijmegen, The Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s00415-020-10231-9
?:hasPublicationType
?:journal
  • Journal of neurology
is ?:pmid of
?:pmid
?:pmid
  • 32964331
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.626
?:rankingScore_hIndex
  • 118
is ?:relation_isRelatedTo_publication of
?:title
  • A word of hope for ataxia trials in COVID-19 time and beyond.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all